[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595901":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":28,"responsibleParty":90,"collaborators":20,"id":92,"slug":93,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":20,"eligibilityCriteria":98,"healthyVolunteers":99,"sex":100,"minAge":101,"maxAge":102,"enrollmentInfo":103,"targetDuration":20,"studyType":106,"phases":107,"briefSummary":109,"conditions":110,"keywords":20,"overallStatus":31,"whyStopped":20,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Sanofi","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Children, adolescents and first-degree relatives of T1D probands","OTHER","Blood samples will be collected from the participants and autoantibody testing will be performed. For participants who test positive for any autoantibodies, another autoantibody test and HbA1C test and Oral Glucose Tolerance Test (OGTT) or CGM (Continuous Glucose Monitoring) will be performed",[13],"Procedure: Investigational Procedure",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Investigational Procedure","It consists of prospective blood sample collection from children, adolescents and first-degree relatives of T1D probands.\n\nStudy without any Investigational Medicinal Product (IMP) administration.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":26,"email":27},"Trial Transparency email recommended (Toll free for US & Canada)","CONTACT","800-633-1610","option 6","Contact-US@sanofi.com",[29,42,53,62,70,75,85],{"facility":30,"status":31,"city":32,"state":33,"zip":20,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":20},"Dasman Diabetes Institute - Site Number: 08","RECRUITING","Kuwait City","Al Asimah \u002F Capital Governorate","Kuwait","KW",{"type":37,"coordinates":38},"Point",[39,40],47.97429,29.367,{"lat":40,"lon":39},{"facility":43,"status":31,"city":44,"state":45,"zip":20,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":52,"contacts":20},"Imam Abdulrahman Bin Faisal University - Site Number: 05","Dammam","Eastern Province","Saudi Arabia","SA",{"type":37,"coordinates":49},[50,51],50.10326,26.43442,{"lat":51,"lon":50},{"facility":54,"status":31,"city":55,"state":56,"zip":20,"country":46,"countryCode":47,"cosmosGeoPoint":57,"geoPoint":61,"contacts":20},"King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01","Jeddah","Mecca Region",{"type":37,"coordinates":58},[59,60],39.18624,21.49012,{"lat":60,"lon":59},{"facility":63,"status":31,"city":64,"state":20,"zip":20,"country":46,"countryCode":47,"cosmosGeoPoint":65,"geoPoint":69,"contacts":20},"King Fahd Medical City - Site Number: 03","Riyadh",{"type":37,"coordinates":66},[67,68],46.72185,24.68773,{"lat":68,"lon":67},{"facility":71,"status":31,"city":64,"state":20,"zip":20,"country":46,"countryCode":47,"cosmosGeoPoint":72,"geoPoint":74,"contacts":20},"King Faisal Specialist Hospital & Research Centre - Site Number: 02",{"type":37,"coordinates":73},[67,68],{"lat":68,"lon":67},{"facility":76,"status":31,"city":77,"state":20,"zip":20,"country":78,"countryCode":79,"cosmosGeoPoint":80,"geoPoint":84,"contacts":20},"Sheikh Khalifa Medical City - Site Number: 07","Abu Dhabi","United Arab Emirates","AE",{"type":37,"coordinates":81},[82,83],54.39696,24.45118,{"lat":83,"lon":82},{"facility":86,"status":31,"city":77,"state":20,"zip":20,"country":78,"countryCode":79,"cosmosGeoPoint":87,"geoPoint":89,"contacts":20},"Sheikh Shakhbout Medical City - Site Number: 06",{"type":37,"coordinates":88},[82,83],{"lat":83,"lon":82},{"type":91,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100595901","early-detection-of-type-1-diabetes-in-first-degree-relatives-of-type-1-diabetes-patients-detect-t1d-gulf-100595901",false,"NCT07038473","Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)","Islet Autoantibody Early Detection in At-risk Children\u002FAdolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries","Inclusion Criteria:\n\n* Children and adolescents, age 1.5 years to 18 years\n* First degree relatives of T1D probands\n* Parent or legal guardian signing an informed consent\n\nExclusion Criteria:\n\n* Already developed clinical overt T1D\n* Known diabetes of any kind (type 1, type 2, Maturity Onset Diabetes of the Young - MODY)\n* Have a previous history of being treated with insulin\n\nThe above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.",true,"ALL","18 Months","18 Years",{"count":104,"type":105},3500,"ESTIMATED","INTERVENTIONAL",[108],"NA","The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).",[111],"Type 1 Diabetes","2026-08-18",{"date":114,"type":115},"2026-08-19","ACTUAL",{"date":117,"type":115},"2025-12-17",{"date":119,"type":105},"2026-12-25",{"name":5,"class":6},7]